Contineum Therapeutics CTNM
NASDAQ CTNM
$10.84 -1.89 (-14.85%)
As of: Sep 29, 2026 · 3:50 PM EDT

Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023)

Updated

Contineum Therapeutics' Interest Coverage Ratio came in at 77.29 for FY2023.

Analysis

Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Contineum Therapeutics 476.97 Mn 476.97 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 335.66
Mar 31, 2023 -55.60
API Access

Contineum Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CTNM&period=max&api_key=YOUR_API_KEY